Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K W Brunner

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
Schweizerische Medizinische Wochenschrift|August 29, 1981
[Long-term tumor-free surviving patients with anaplastic small cell bronchial cancer]R Joss, Y Kapanci, J J Widmann, et al.
Schweizerische Medizinische Wochenschrift|November 4, 1972
[Therapy of generalized Hodgkin's disease. Results of cooperative studies (1967-1972)]C Sauter, K W Brunner, H J Senn, et al.
Cancer Treatment Reviews|September 1, 1984
New agents in non-small cell lung cancerR A Joss, F Cavalli, A Goldhirsch, et al.
British Journal of Cancer|September 1, 1993
Bioavailability and feasibility of subcutaneous 5-fluorouracilM M Borner, J Kneer, C Crevoisier, et al.
Schweizerische Medizinische Wochenschrift|June 6, 1981
[Results of, and indications for adjuvant chemotherapy in breast cancer]K W Brunner, A Goldhirsch, R Joss, et al.
Schweizerische Medizinische Wochenschrift|October 13, 1984
[Adenocarcinoma of the kidney (hypernephroma)]W Probst, R Joss, J Triller, et al.
Schweizerische Medizinische Wochenschrift|February 22, 1975
[Initial results with a epipodophyllotoxin derivative VP 16-213 in the treatment of acute leukemia]F Cavalli, H J Ryssel, K Batz, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibilityT Cerny, A Graf, P Rohner, et al.
Medical and Pediatric Oncology|January 1, 1981
Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancerA Goldhirsch, R A Joss, F Cavalli, et al.
Cancer Treatment Reports|March 1, 1978
VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedulesF Cavalli, R W Sonntag, F Jungi, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
Schweizerische Medizinische Wochenschrift|August 29, 1981
[Long-term tumor-free surviving patients with anaplastic small cell bronchial cancer]R Joss, Y Kapanci, J J Widmann, et al.
Schweizerische Medizinische Wochenschrift|November 4, 1972
[Therapy of generalized Hodgkin's disease. Results of cooperative studies (1967-1972)]C Sauter, K W Brunner, H J Senn, et al.
Cancer Treatment Reviews|September 1, 1984
New agents in non-small cell lung cancerR A Joss, F Cavalli, A Goldhirsch, et al.
British Journal of Cancer|September 1, 1993
Bioavailability and feasibility of subcutaneous 5-fluorouracilM M Borner, J Kneer, C Crevoisier, et al.
Schweizerische Medizinische Wochenschrift|June 6, 1981
[Results of, and indications for adjuvant chemotherapy in breast cancer]K W Brunner, A Goldhirsch, R Joss, et al.
Schweizerische Medizinische Wochenschrift|October 13, 1984
[Adenocarcinoma of the kidney (hypernephroma)]W Probst, R Joss, J Triller, et al.
Schweizerische Medizinische Wochenschrift|February 22, 1975
[Initial results with a epipodophyllotoxin derivative VP 16-213 in the treatment of acute leukemia]F Cavalli, H J Ryssel, K Batz, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibilityT Cerny, A Graf, P Rohner, et al.
Medical and Pediatric Oncology|January 1, 1981
Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancerA Goldhirsch, R A Joss, F Cavalli, et al.
Cancer Treatment Reports|March 1, 1978
VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedulesF Cavalli, R W Sonntag, F Jungi, et al.
Pageof 15